Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Parnell Pharmaceuticals Holdings Ltd (PARNF)

Parnell Pharmaceuticals Holdings Ltd (PARNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Parnell Pharmaceuticals Holdings Ltd UNIT 4 CENTURY ESTATE 476 GARDENERS ROAD ALEXANDRIA C3 2015 AUS

www.parnell.com P: 61-2-9667-4411

Description:

Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.

Key Statistics

Overview:

Market Capitalization, $K 8
Enterprise Value, $K 40,758
Shares Outstanding, K 82,953
Annual Sales, $ 27,220 K
Annual Net Income, $ -1,070 K
EBIT, $ 0 K
EBITDA, $ 8,230 K
60-Month Beta 19.95
% of Institutional Shareholders 0.00%
Float, K 82,953
% Float 100.00%
Short Volume Ratio 0.17

Growth:

1-Year Return -95.83%
3-Year Return -99.96%
5-Year Return -99.99%
5-Year Revenue Growth 83.30%
5-Year Earnings Growth 96.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/15/23
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PARNF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -3.93%
Debt/Equity -1.69
Price/Sales N/A
Price/Cash Flow 0.00
Price/Book N/A
Book Value/Share -1.31
Interest Coverage -0.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar